Literature DB >> 10942214

Dexamethasone induced cardiac hypertrophy in newborn rats is accompanied by changes in myosin heavy chain phenotype and gene transcription.

S Muangmingsuk1, P Ingram, M P Gupta, R A Arcilla, M Gupta.   

Abstract

Cardiac hypertrophy has been observed in newborn infants treated with dexamethasone (DEX). This study was undertaken to examine whether DEX-induced hypertrophy in newborn rats is associated with redistribution of cardiac myosin heavy chain (MHC) isoforms and, if so, the effects involve transcriptional regulation. Newborn rats were injected with either DEX (1 mg/kg/day; s.c.) or equivalent volume normal saline for 1, 3, 5, 7 or 9 days. Hypertrophy was quantified by heart dry/wet wt ratios, heart/body wt ratios, and total protein content of the myocardium. Changes in the expression of cardiac MHC mRNA were characterized by northern blot and slot blot analyses, using isoform specific probes for alpha- and beta-MHC genes. DEX effect on alpha-MHC gene transcription was analyzed by transiently transfecting various alpha-MHC promoter/CAT reporter constructs into primary cultures of cardiac myocytes derived from one day old rat pups. DEX administration into newborn rats produced significant cardiac hypertrophy ranging from 23% at day 1 to 59% at 9 days. The hypertrophy was accompanied by immediate increase (83%) in steady state level of the alpha-MHC mRNA within one day and a maximum increase (148%) at 7 days of treatment. The steady state level of beta-MHC mRNA declined by 25% at day 1 and a maximum decrease of 54% at day 7 of DEX treatment. The changes in MHC mRNA were also reflected in their protein levels as determined by V1 and V3 isozyme analysis. DEX treatment of primary cultures of cardiomyocytes following transfection with alpha-MHC promoter/CAT reporter constructs resulted in increased CAT expression in a dose dependent manner. The minimum alpha-MHC gene sequences responding to DEX treatment were located between the -200 to -74-bp region of the gene, resulting in 2-fold and 6-fold activation of CAT reporter after 0.05 and 0.1 mM doses of DEX, respectively. Our data indicate that DEX induced cardiac hypertrophy in newborn rats is accompanied by increased expression of alpha-MHC and decreased expression of beta-MHC. The alpha-MHC effects are mediated in part through transcriptional mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942214     DOI: 10.1023/a:1007128300430

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  45 in total

1.  Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia.

Authors:  J C Werner; R E Sicard; T W Hansen; E Solomon; R M Cowett; W Oh
Journal:  J Pediatr       Date:  1992-02       Impact factor: 4.406

Review 2.  Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia.

Authors:  B L Ohning; D A Fyfe; P A Riedel
Journal:  Am Heart J       Date:  1993-01       Impact factor: 4.749

3.  The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats.

Authors:  T F Schaible; A Malhotra; G Ciambrone; J Scheuer
Journal:  Circ Res       Date:  1984-01       Impact factor: 17.367

4.  Expression of cardiac angiotensin II AT1 receptor genes in rat hearts is regulated by steroids but not by angiotensin II.

Authors:  R Della Bruna; S Ries; C Himmelstoss; A Kurtz
Journal:  J Hypertens       Date:  1995-07       Impact factor: 4.844

5.  Effects of gonadectomy and hormonal replacement on rat hearts.

Authors:  J Scheuer; A Malhotra; T F Schaible; J Capasso
Journal:  Circ Res       Date:  1987-07       Impact factor: 17.367

6.  Steroid-hormone regulation of myosin subunit expression in smooth and cardiac muscle.

Authors:  T Calovini; H Haase; I Morano
Journal:  J Cell Biochem       Date:  1995-09       Impact factor: 4.429

7.  Biochemical correlates of dexamethasone-induced relative cardiomegaly in neonatal rats.

Authors:  R E Sicard; J C Werner
Journal:  In Vivo       Date:  1995 Jan-Feb       Impact factor: 2.155

8.  Tissue-restricted expression of the cardiac alpha-myosin heavy chain gene is controlled by a downstream repressor element containing a palindrome of two ets-binding sites.

Authors:  M Gupta; R Zak; T A Libermann; M P Gupta
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

9.  Regulation of myosin isoenzyme composition in fetal and neonatal rat ventricle by endogenous thyroid hormones.

Authors:  R A Chizzonite; R Zak
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

10.  Distal cis-acting promoter sequences mediate glucocorticoid stimulation of cardiac atrial natriuretic factor gene transcription.

Authors:  S Argentin; Y L Sun; I Lihrmann; T J Schmidt; J Drouin; M Nemer
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

View more
  7 in total

1.  Cardiac effects of a single course of antenatal betamethasone in preterm infants.

Authors:  M Vural; I Yilmaz; F Oztunç; B Ilikkan; E Erginöz; Y Perk
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-12-06       Impact factor: 5.747

2.  Dexamethasone promotes hypertrophy of H9C2 cardiomyocytes through calcineurin B pathway, independent of NFAT activation.

Authors:  K N Sangeetha; B S Lakshmi; S Niranjali Devaraj
Journal:  Mol Cell Biochem       Date:  2015-10-29       Impact factor: 3.396

3.  Dexamethasone-induced cardiac deterioration is associated with both calcium handling abnormalities and calcineurin signaling pathway activation.

Authors:  Fabiana de Salvi Guimarães; Wilson Max Almeida Monteiro de Moraes; Luis Henrique Marchesi Bozi; Pâmela R Souza; Ednei Luiz Antonio; Danilo Sales Bocalini; Paulo José Ferreira Tucci; Daniel Araki Ribeiro; Patricia Chakur Brum; Alessandra Medeiros
Journal:  Mol Cell Biochem       Date:  2016-10-19       Impact factor: 3.396

4.  Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis.

Authors:  Rongqin Ren; Robert H Oakley; Diana Cruz-Topete; John A Cidlowski
Journal:  Endocrinology       Date:  2012-09-18       Impact factor: 4.736

5.  A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids.

Authors:  Kobra Haghighi; Guoli Chen; Yoji Sato; Guo-Chang Fan; Suiwen He; Fotis Kolokathis; Luke Pater; Ioannis Paraskevaidis; W Keith Jones; Gerald W Dorn; Dimitrios Th Kremastinos; Evangelia G Kranias
Journal:  Hum Mutat       Date:  2008-05       Impact factor: 4.878

6.  [Neonatal hypertrophic cardiomyopathy of difficult etiologic diagnosis].

Authors:  Rania Hammami; Sana Ouali; Ilyes Naffeti; Sami Hammas; Slim Kacem; Rim Gribaa; Fahmi Remedi; Essia Boughzela
Journal:  Pan Afr Med J       Date:  2011-12-19

7.  Abrogation of Nrf2 impairs antioxidant signaling and promotes atrial hypertrophy in response to high-intensity exercise stress.

Authors:  Radhakrishnan Rajesh Kumar; Madhusudhanan Narasimhan; Gobinath Shanmugam; Jennifer Hong; Asokan Devarajan; Sethu Palaniappan; Jianhua Zhang; Ganesh V Halade; Victor M Darley-Usmar; John R Hoidal; Namakkal S Rajasekaran
Journal:  J Transl Med       Date:  2016-04-05       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.